株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ジカウイルス検査の世界市場:診断試験のタイプ、エンドユーザー、地理別の成長率、動向および予測

Zika Virus Testing Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 659355
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.11円で換算しております。
Back to Top
ジカウイルス検査の世界市場:診断試験のタイプ、エンドユーザー、地理別の成長率、動向および予測 Zika Virus Testing Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年02月01日 ページ情報: 英文 120 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

世界のジカウイルス検査市場は、2018年から2023年の予測期間中に、約5.5%のCAGRで成長する見通しです。ジカウイルスはファルビウイルス属に属し、ネッタイシマカによって伝染します。市場は主に研究開発活動の増加とジカウイルス感染の増加によって成長が促進されています。地域別には、ヘルスケアインフラストラクチャーの整備が進んでおり、ジカウイルスの検査でいくつかのバイオ医薬品企業が急速に技術を進歩させているため、北米が市場を支配すると予測されています。

当レポートでは、世界のジカウイルス検査市場を調査し、全体的な市場動向、製品・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品およびサービスの脅威
    • 業界内での競争
  • パイプライン分析
  • 規制シナリオ

第6章 成長要因、阻害要因、機会、課題の分析(DROC)

  • 市場の成長要因
    • ジカウイルス感染症の流行
    • 革新的なテストを開発する政府のイニシアチブ
    • バイオ医薬品企業による研究開発の増加
    • 医療診断における技術的進歩
  • 市場の阻害要因
    • テストキットの高コスト
    • 新興市場における新技術の採用の遅さ
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 診断テストの種類別
    • 分子試験
    • 血清学的検査
    • プラーク減少中和試験(PRNT)
  • エンドユーザー
    • 病院/クリニック
    • 研究/診断研究所
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • M&A分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要企業

  • Abbott
  • Altona Diagnostics GmbH
  • Chembio Diagnostic Systems Inc.
  • ELITechGroup
  • F. Hoffmann-La Roche Ltd
  • Fast Track Diagnostics Ltd
  • Genekam
  • Luminex Corporation
  • Primerdesign Ltd
  • Quest Diagnostics

第10章 市場の将来展望

目次
Product Code: 61716

Zika virus (ZIKV) infection has been known to be endemic in Africa and Southeast Asia. The consequent viral spread over the Pacific region led to an outbreak in the developed and emerging countries, worldwide. According to the World Health Organization (WHO), about 84 countries/territories are or have been previously infected by ZIKV transmission. There have been major outbreaks of Zika virus infection in Asia-Pacific (particularly India) and South American countries. As per the Centers for Disease Control and Prevention, Mexico, South America, Central, and Sub-Saharan African countries, and several countries in Southeast Asia are the major countries at risk for the growth of Zika virus infection. Thus, the rising prevalence of Zika virus infection is one of the primary factors driving the growth of the market studied, over the forecast period.

The other prominent drivers of the market studied are increasing R&D by biopharmaceutical companies, and technological advancements in diagnostic tests.

Key Market Trends

Serologic Test Segment is Expected to Show Better Growth in the Forecast Years

The Zika Virus Testing market has been segmented based on test type and end-user. The test type is further segmented into Molecular Test and Serologic Test. The serologic test is expected to grow due to their increased preference as they can detect acute as well as late-stage zika virus infection. In addition, emerging rapid detection serological diagnostics offer shorter turnaround time as well as the differential diagnosis of Zika against other flaviviruses. Furthermore, zika in early pregnancy increases risk of birth defects. According to the CDC, birth defects cases were reported in a higher proportion of babies whose mothers were infected with the zika virus during the first trimester of pregnancy. The virus can be transmitted from an infected pregnant woman to a fetus and causes microcephaly and other severe brain anomalies. This has prompted the testing of pregnant women for the Zika virus, further fueling the growth of the market.

North America Dominates the Market and is Expected to Follow the Same Trend Over the Forecast Period

North America is expected to dominate the market studied. The growth can be attributed to the rising awareness of the advantages of testing kits. The government organizations, such as the Centers for Disease Control and Prevention (CDC), Pan American Health Organization (PAHO), etc., have been mainly involved in the prevention of Zika virus infection. As per the CDC, About 2 in 20 (10%) babies of women with confirmed Zika virus infection during pregnancy in US states and about 1 in 20 (5%) in US territories had Zika-associated birth defects. The CDC has received funding, to combat the zika outbreak across several territories. In addition, the developed healthcare infrastructure, along with rapid technological advancements by several biopharmaceutical companies in the testing of the zika virus is expected to positively impact the market.

Competitive Landscape

The global players in the Zika Virus Testing market are Abbott Laboratories, Altona Diagnostics GmbH, Chembio Diagnostic Systems Inc., ELITechGroup, F. Hoffmann-La Roche Ltd, Genekam, Luminex Corporation, Novacyt Group, Quest Diagnostics and Siemens AG.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Zika Virus Infection
    • 4.2.2 Increasing R&D by Biopharmaceutical Companies
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Testing Kits
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Test Type
    • 5.1.1 Molecular Test
    • 5.1.2 Serologic Test
  • 5.2 By End User
    • 5.2.1 Hospital/Clinic
    • 5.2.2 Diagnostics Laboratory
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Altona Diagnostics GmbH
    • 6.1.3 Chembio Diagnostic Systems Inc.
    • 6.1.4 ELITechGroup
    • 6.1.5 F. Hoffmann-La Roche Ltd
    • 6.1.6 Genekam
    • 6.1.7 Luminex Corporation
    • 6.1.8 Novacyt Group
    • 6.1.9 Quest Diagnostics
    • 6.1.10 Siemens AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top